The global virus purification kits market revenue was around US$ 1.5 billion in 2022 and is estimated to reach US$ 3.83 billion by 2031, growing at a compound annual growth rate (CAGR) of ~11% during the forecast period from 2023 to 2031.
Virus purification kits offer quick and easy techniques to focus and purify viral vectors from cell culture medium and cell lysate. Many vaccines are created from cell-culture-derived virus particles.
Market Driving Factors
The demand for virus purification kits increased amidst the COVID-19 pandemic. Therefore, scientists have made efforts to yield purified RNA (Ribonucleic acid) of the highest integrity that can be helpful in downstream applications. Procedures such as lysate preparation, reagent preparation, and RNA purification, among others, are anticipated to boost due to the surge in the demand for vaccines. This is predicted to fuel the virus purification kits market.
Adenovirus purification kits eliminate the requirement for time-consuming ultracentrifugation procedures driving the market growth. This is due to the innovations in kits that assist in delivering fast and efficient purification of recombinant viruses. For instance, BioVision supplier of high-quality assay kits has a wide product portfolio in lentivirus, adenovirus, and retrovirus purification kits.
High prices involving complicated procedures for gene therapy and vaccine production restrain the market growth.
Regional Analysis
North America dominated the market. This can be attributed to the favorable guidelines & regulatory procedures established by governments for biopharmaceutical industries in the region. Furthermore, the highly developed healthcare sector, surge in preference for biopharmaceuticals over conventional counterparts, and constant evolution of technology boost the market in the region.
Asia Pacific is estimated to dominate the market. This is due to the increase in the number of road casualties and trauma cases. Increasing government support for industrialization, the surge in the presence of Contract Research Organizations (CROs), the availability of labor at a low price, and a moderately less strict regulatory environment are attracting manufacturers of medical and biologics devices for market expansion in the region.
Segmentation Insights
Virus Type Insight
The adenovirus segment dominated the market. This can be attributed to the higher yield of adenovirus particles by the latest virus purification kits, major application in viral vector-based drugs, and surge in incidence of adenovirus-associated respiratory diseases.
End User Insight
The biopharmaceutical and biotechnology companies segment dominate the market. This is due to the surge in R&D (Research and Development) activities, biologics production, and biopharmaceutical industry growth. Furthermore, the surge in demand for innovative vaccines and drugs, advances in scientific research and development, and support of government policies and schemes are boosting the segment.
The contract research organizations (CROs) segment is anticipated to grow at the fastest CAGR over the projection period. This is due to the trend of outsourcing R&D and manufacturing in CROs. In addition, the rise in the number of therapeutic protein and vaccine manufacturing companies has led to increased demand for outsourcing services that cater to the specific requirements of these companies.
Prominent Companies
Segmentation Outline
The global virus purification kits market segmentation focuses on Technology, Virus Type, End User, and Region.
By Technology
By Virus Type
By End User
By Region
[TABLE OF CONTENTS]
1 INTRODUCTION OF GLOBAL VIRUS PURIFICATION KITS MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY: VIRUS PURIFICATION KITS MARKET
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
3.5 ANALYST TOOLS AND MODELS
4 GLOBAL VIRUS PURIFICATION KITS MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS AND TRENDS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE ANALYSIS
4.4 VALUE CHAIN ANALYSIS
4.5 MARKET GROWTH AND OUTLOOK
4.5.1 PRICE TREND ANALYSIS
4.5.2 OPPORTUNITY SHARE
5 GLOBAL VIRUS PURIFICATION KITS MARKET, BY TECHNOLOGY
5.1 OVERVIEW
5.2 ULTRACENTRIFUGATION
5.3 CHROMATOGRAPHY
5.4 NANOFILTRATION
5.5 OTHERS
6 GLOBAL VIRUS PURIFICATION KITS MARKET, BY VIRUS TYPE
6.1 OVERVIEW
6.2 ADENOVIRUS
6.3 LENTIVIRUS
6.4 RETROVIRUS
6.5 OTHERS
7 GLOBAL VIRUS PURIFICATION KITS MARKET, BY END USER
7.1 OVERVIEW
7.2 ACADEMIC & RESEARCH INSTITUTES
7.3 BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
7.4 CONTRACT RESEARCH ORGANIZATIONS (CROS)
7.5 OTHERS
8 GLOBAL VIRUS PURIFICATION KITS MARKET, BY GEOGRAPHY
8.1 OVERVIEW
8.2 NORTH AMERICA
8.2.1 NORTH AMERICA MARKET SNAPSHOT
8.2.2 U.S.
8.2.3 CANADA
8.2.4 MEXICO
8.3 EUROPE
8.3.1 EUROPE MARKET SNAPSHOT
8.3.2 WESTERN EUROPE
8.3.2.1 THE UK
8.3.2.2 GERMANY
8.3.2.3 FRANCE
8.3.2.4 ITALY
8.3.2.5 SPAIN
8.3.2.6 REST OF WESTERN EUROPE
8.3.3 EASTERN EUROPE
8.3.3. 1 POLAND
8.3.3.2 RUSSIA
8.3.3.3 REST OF EASTERN EUROPE
8.4 ASIA PACIFIC
8.4.1 ASIA PACIFIC MARKET SNAPSHOT
8.4.2 CHINA
8.4.3 JAPAN
8.4.4 INDIA
8.4.5 AUSTRALIA & NEW ZEALAND
8.4.6 ASEAN
8.4.7 REST OF ASIA PACIFIC
8.5 MIDDLE EAST & AFRICA
8.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
8.5.2 UAE
8.5.3 SAUDI ARABIA
8.5.4 SOUTH AFRICA
8.5.5 REST OF MEA
8.6 SOUTH AMERICA
8.6.1 SOUTH AMERICA MARKET SNAPSHOT
8.6.2 BRAZIL
8.6.3 ARGENTINA
8.6.4 REST OF SOUTH AMERICA
9 GLOBAL VIRUS PURIFICATION KITS MARKET COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 COMPANY MARKET RANKING
9.3 KEY DEVELOPMENT STRATEGIES
9.4 COMPETITIVE DASHBOARD
9.5 PRODUCT MAPPING
9.6 TOP PLAYER POSITIONING, 2022
9.7 COMPETITIVE HEATMAP
9.8 TOP WINNING STRATEGIES
10 COMPANY PROFILES
10.1 MERCK KGAA
10.1.1 OVERVIEW
10.1.2 FINANCIAL PERFORMANCE
10.1.3 PRODUCT OUTLOOK
10.1.4 KEY DEVELOPMENTS
10.1.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.2 DANAHER CORPORATION
10.2.1 OVERVIEW
10.2.2 FINANCIAL PERFORMANCE
10.2.3 PRODUCT OUTLOOK
10.2.4 KEY DEVELOPMENTS
10.2.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.3 THERMO FISHER SCIENTIFIC INC
10.3.1 OVERVIEW
10.3.2 FINANCIAL PERFORMANCE
10.3.3 PRODUCT OUTLOOK
10.3.4 KEY DEVELOPMENTS
10.3.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.4 SARTORIUS AG
10.4.1 OVERVIEW
10.4.2 FINANCIAL PERFORMANCE
10.4.3 PRODUCT OUTLOOK
10.4.4 KEY DEVELOPMENTS
10.4.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.5 LONZA GROUP LTD
10.5.1 OVERVIEW
10.5.2 FINANCIAL PERFORMANCE
10.5.3 PRODUCT OUTLOOK
10.5.4 KEY DEVELOPMENTS
10.5.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.6 ASAHI KASEI CORPORATION
10.6.1 OVERVIEW
10.6.2 FINANCIAL PERFORMANCE
10.6.3 PRODUCT OUTLOOK
10.6.4 KEY DEVELOPMENTS
10.6.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.7 BIOVISION INC
10.7.1 OVERVIEW
10.7.2 FINANCIAL PERFORMANCE
10.7.3 PRODUCT OUTLOOK
10.7.4 KEY DEVELOPMENTS
10.7.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.8 PENDOTECH
10.8.1 OVERVIEW
10.8.2 FINANCIAL PERFORMANCE
10.8.3 PRODUCT OUTLOOK
10.8.4 KEY DEVELOPMENTS
10.8.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.9 QIAGEN
10.9.1 OVERVIEW
10.9.2 FINANCIAL PERFORMANCE
10.9.3 PRODUCT OUTLOOK
10.9.4 KEY DEVELOPMENTS
10.9.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.10 TAKARA BIO INC
10.10.1 OVERVIEW
10.10.2 FINANCIAL PERFORMANCE
10.10.3 PRODUCT OUTLOOK
10.10.4 KEY DEVELOPMENTS
10.10.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
01
お客様のニーズに合わせてレポートをカスタマイズ可能
02
ベテランの市場調査員による専門的な分析
03
安全で簡単に利用できるオンライン決済方法
04
お客様のご要望に応じて、特定の章を購入することができます。
05
すべてのレポートに専門的な日本語翻訳を提供
06
包括的でわかりやすいレポートを迅速にお届けします。
07
購入後も継続的なサポートとアップデートが受けられます。
We Accept
Copyright ©2022 All rights reserved